Deadline: 24 January 2025
The Arthritis National Research Foundation and Pediatric Dermatology Research Alliance are pleased to announce the release of the 2025 Rheum for Kids: Pediatric Skin and Joint Grant to provide financial support to early career researchers studying diseases affecting pediatric joints and skin, who are within seven years of their latest stage of training.
The Pediatric Dermatology Research Alliance (PeDRA) is a collaborative research network, providing a platform from which pediatric dermatologists organize studies and collaborate, while also supporting individuals embarking on early-stage research that may or may not benefit from collaboration in future.
Pooling resources and linking investigators together multiplies the power of each individual clinician scientist many-fold. With more than 600 members representing more than 180 institutions, PeDRA is accelerating research and bringing us closer to new treatment opportunities for children and families living with dermatologic conditions and diseases.
Goal
- PeDRA and ANRF are committed to nurturing the next generation of leaders in pediatric skin and joint disease research. They are pleased to provide the opportunity to support early career researchers in their pursuit of innovative and impactful research projects. The goal is to advance high-impact research endeavors by cultivating cross-disciplinary research teams spanning pediatric dermatology and pediatric rheumatology.
Scope
- This call is for all types of applications relating to pediatric rheumatology and dermatology, including but not limited to juvenile arthritis, psoriasis, lupus, dermatomyositis, and morphea or an underlying mechanism that may affect these or other conditions affecting both the skin and joints.
- Candidates for the Rheum for Kids: Pediatric Skin and Joint Grant are qualified, promising investigators with a clear upward trajectory, ideally within seven years of their latest stage of training, and can demonstrate a strong mentorship support system.
Funding Information
- Grants will be funded for 1 year and awarded up to a total of $50,000.
Eligibility Criteria
- Clinical and basic/foundational studies will be considered. Clinical studies should have a translational component that helps reveal the underlying mechanisms or response to therapy.
- One application may be submitted per individual or lab annually. It is highly encouraged that interested applicants discuss the desire to apply with their lab and mentor or supervisor. If multiple applicants from the same lab submit an application, only the first application submitted will be reviewed.
- Investigators must possess either an M.D. and/or Ph.D. degree or equivalent.
- Applicants are not required to be U.S. citizens.
- Applicants must be affiliated with, and complete all grant-funded research, at a qualified U.S. nonprofit research institution.
- Preference will be given to postdoctoral investigators, fellows, and early career researchers transitioning to independent investigator status, who are within seven years of their postdoctoral training.
- Applicants may not have, or ever had, an NIH RO1 grant or equivalent. Do not apply if you’ve had an NIH RO1 or equivalent support.
For more information, visit ANRF.